A study of the probit model with latent variables in Phase I clinical trials (Q5220814)
From MaRDI portal
!
This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use the normal view instead:
scientific article; zbMATH DE number 7183154
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | A study of the probit model with latent variables in Phase I clinical trials |
scientific article; zbMATH DE number 7183154 |
Statements
A study of the probit model with latent variables in Phase I clinical trials (English)
0 references
27 March 2020
0 references
Bayesian method
0 references
continual reassessment method
0 references
dose finding
0 references
latent variable
0 references
Markov chain Monte Carlo
0 references
phase I clinical trial
0 references
probit model
0 references
0 references
0 references
0 references
0 references
0.8657824
0 references
0.84428734
0 references
0.84311676
0 references
0.83784306
0 references
0.8357069
0 references
